ArticleScientific data2026
FAIR data gaps and collaboration willingness among hemoglobinopathy research centers.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hemoglobinopathies, including thalassemia syndromes and sickle cell disease, require interoperable and well-annotated data systems to support multi-center research and coordinated care. However, existing datasets rarely adhere to the Findable, Accessible, Interoperable, and Reusable (FAIR) principles. We conducted a cross-sectional, web-based survey (September 2024-March 2025) among data professionals, clinicians, and researchers within the HELIOS network to evaluate data management practices, metadata use, standards adoption, and collaboration readiness. Forty-four eligible institutional responses from 22 countries were analyzed. Half of the centers reported basic metadata documentation, 20% used recognized ontologies, and none implemented common data models such as OMOP or CDISC, and only isolated mentions of HL7 FHIR were observed. Core datasets like demographics, laboratory results, and genotypes were widely available, while advanced data types such as omics and imaging were limited. Despite limited FAIR compliance, most respondents expressed willingness to participate in federated (86%) or centralized (68%) data sharing. This study provides a structured international overview of FAIR-related gaps and collaborative potential across hemoglobinopathy centers globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.